Medpace Holdings, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 69.92

Medpace Holdings, Inc. Revenue Per Share is USD 69.92 for the Trailing 12 Months (TTM) ending March 31, 2025, a 9.30% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Medpace Holdings, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 63.97, a 28.61% change year over year.
  • Medpace Holdings, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 49.74, a 41.22% change year over year.
  • Medpace Holdings, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 35.22, a 31.17% change year over year.
  • Medpace Holdings, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 26.85, a 8.36% change year over year.
Key Data
Date Revenue Per Share Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio